TBIO
Translate Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 13th of September, 2021.
133 hedge funds and large institutions have $1.19B invested in Translate Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 46 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
27% more call options, than puts
Call options by funds: $6.25M | Put options by funds: $4.94M
Holders
133
Holding in Top 10
5
Calls
$6.25M
Puts
$4.94M
Top Buyers
| 1 | +$32M | |
| 2 | +$26.6M | |
| 3 | +$21.5M | |
| 4 |
Millennium Management
New York
|
+$21M |
| 5 |
KSCM
Key Square Capital Management
Stamford,
Connecticut
|
+$18.1M |
Top Sellers
| 1 | -$24.3M | |
| 2 | -$13.7M | |
| 3 | -$7.63M | |
| 4 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
-$3.21M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.93M |